MARRE HENRY: Open Payments
NPI 1891719076 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 74 payments from 17 companies in 2025. Trend: 2023 $673 · 2024 $1,371 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $467 |
| Madrigal Pharmaceuticals | 9 | $289 |
| Janssen Biotech, Inc. | 8 | $158 |
| Regeneron Healthcare Solutions, Inc. | 5 | $147 |
| Lilly USA, LLC | 9 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $121 |
| PFIZER INC. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| GENZYME CORPORATION | 2 | $51 |
Products named: REZDIFFRA, RINVOQ, DUPIXENT, TREMFYA, OMVOH, XIFAXAN, CREON, SKYRIZI.
Industry payments across GA — which companies pay providers there.
